PowderMed Files for Human Testing of H5N1 DNA Vaccine

Here's a recent story from Reuters about PowederMed's vaccine.

The first-time-in-man clinical trial will be conducted at a clinical research unit in London and will examine the ability of a vaccine based upon the Vietnam H5N1 avian influenza strain to protect against a potential pandemic form of flu.